Interestingly, the role of E2F1 in NB prognosis has recently been demonstrated in a large investigation by Wang et al. [26], who reported an association between the gene expression and both MYCN amplification and a higher age at diagnosis, two major indicators of poor prognosis in NB patients. The gene discussed is E2F1; the disease is neuroblastoma.